Chon Lai
Impact in
-
- Epigenetics and DNA Methylation
- Histone Deacetylase Inhibitors Research
- Melanoma and MAPK Pathways
- Cancer-related gene regulation
- Protein Degradation and Inhibitors
Papers in
-
- Histone Deacetylase Inhibitors Research 5
- Epigenetics and DNA Methylation 4
- Protein Degradation and Inhibitors 2
- Melanoma and MAPK Pathways 2
- Ubiquitin and proteasome pathways 2
- Genomics and Chromatin Dynamics 2
- Oncology 3
- HER2/EGFR in Cancer Research 1
- Cytokine Signaling Pathways and Interactions 1
- Co-authors
- Lihong Shi (5 shared papers)James M. Veal (4 shared papers)Gary Larson (2 shared papers)Andreas Maderna (1 shared paper)Robert Hamatake (2 shared papers)Ryan Stansfield (4 shared papers)Jean‐Michel Vernier (3 shared papers)Todd Vo (2 shared papers)
- Journals
- Molecular Cancer Therapeutics (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)ACS Medicinal Chemistry Letters (1 paper)Journal of Medicinal Chemistry (1 paper)The American Journal of Gastroenterology (1 paper)
- Partner nations
- United StatesSwitzerlandItaly
In The Last Decade
Chon Lai
9 papers receiving 356 citations
Peers
Comparison fields: 5 of 52
- Molecular Biology 286
- Oncology 72
- Pathology and Forensic Medicine 41
- Organic Chemistry 57
- Cancer Research 29
Countries citing papers authored by Chon Lai
This map shows the geographic impact of Chon Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chon Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chon Lai more than expected).
Fields of papers citing papers by Chon Lai
This network shows the impact of papers produced by Chon Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chon Lai. The network helps show where Chon Lai may publish in the future.
Co-authors
The 25 scholars most cited alongside Chon Lai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 153 | |
| 2 | 2020 | 92 | |
| 3 | 2017 | 51 | |
| 4 | 2018 | 32 | |
| 5 | 2023 | 15 | |
| 6 | 2018 | 12 | |
| 7 | 2024 | 4 | |
| 8 | RDEA119: A potent and highly selective MEK inhibitor for the treatment of cancer | 2007 | 3 |
| 9 | 2008 | 2 | |
| 10 | 2025 | 0 |
About Chon Lai
Chon Lai is a scholar working on Molecular Biology, Oncology, Public Health, Environmental and Occupational Health, Immunology and Allergy and Infectious Diseases, having authored 10 papers that have together received 364 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (5 papers), Epigenetics and DNA Methylation (4 papers), Protein Degradation and Inhibitors (2 papers), Melanoma and MAPK Pathways (2 papers), Ubiquitin and proteasome pathways (2 papers), Genomics and Chromatin Dynamics (2 papers), HER2/EGFR in Cancer Research (1 paper) and Cytokine Signaling Pathways and Interactions (1 paper). The work is most often cited by research in Molecular Biology (286 citations), Oncology (72 citations), Pathology and Forensic Medicine (41 citations), Organic Chemistry (57 citations) and Cancer Research (29 citations). Chon Lai has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include Lihong Shi, James M. Veal, Gary Larson, Andreas Maderna, Robert Hamatake, Ryan Stansfield, Jean‐Michel Vernier, Todd Vo, T.C. Appleby and Jeffrey N. Miner. Their work appears in journals such as Molecular Cancer Therapeutics, Bioorganic & Medicinal Chemistry Letters, ACS Medicinal Chemistry Letters, Journal of Medicinal Chemistry and The American Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.